↓ Skip to main content

New Directions for the Treatment of Adrenal Insufficiency

Overview of attention for article published in Frontiers in endocrinology, May 2015
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
60 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
New Directions for the Treatment of Adrenal Insufficiency
Published in
Frontiers in endocrinology, May 2015
DOI 10.3389/fendo.2015.00070
Pubmed ID
Authors

Gerard Ruiz-Babot, Irene Hadjidemetriou, Peter James King, Leonardo Guasti

Abstract

Adrenal disease, whether primary, caused by defects in the hypothalamic-pituitary-adrenal (HPA) axis, or secondary, caused by defects outside the HPA axis, usually results in adrenal insufficiency, which requires lifelong daily replacement of corticosteroids. However, this kind of therapy is far from ideal as physiological demand for steroids varies considerably throughout the day and increases during periods of stress. The development of alternative curative strategies is therefore needed. In this review, we describe the latest technologies aimed at either isolating or generating de novo cells that could be used for novel, regenerative medicine application in the adrenocortical field.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Italy 1 2%
Unknown 59 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 14 23%
Student > Bachelor 10 17%
Student > Ph. D. Student 7 12%
Student > Postgraduate 6 10%
Student > Master 6 10%
Other 10 17%
Unknown 7 12%
Readers by discipline Count As %
Medicine and Dentistry 25 42%
Biochemistry, Genetics and Molecular Biology 14 23%
Agricultural and Biological Sciences 6 10%
Chemistry 2 3%
Nursing and Health Professions 1 2%
Other 4 7%
Unknown 8 13%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 May 2015.
All research outputs
#15,666,573
of 25,604,262 outputs
Outputs from Frontiers in endocrinology
#3,582
of 13,243 outputs
Outputs of similar age
#143,568
of 279,587 outputs
Outputs of similar age from Frontiers in endocrinology
#23
of 61 outputs
Altmetric has tracked 25,604,262 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,243 research outputs from this source. They receive a mean Attention Score of 5.0. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 279,587 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 61 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.